Women's & Reproductive Health
Includes technologies from the women’s and reproductive health spaces including infertility, contraception, gynecological disorders as well as female-specific cancers like ovarian, uterine, and breast.
Search text
Med-Computational and Systems Biology
1 result
(0.04 seconds)
In vitro data confirm STL001’s ability to sensitize diverse cancer cell lines to chemotherapy, including AML, triple-negative breast cancer, colorectal, ovarian, and prostate cancers. • Triple-Negative and Tamoxifen-Resistant Breast Cancer.